Grail's Galleri Screens for 50 Cancers. Insurers Won't Pay Yet

Grail's Galleri test screens for 50 cancers from one blood draw, but a major study failed to prove detection of later-stage cancers, leaving Medicare coverage to hinge on FDA approval.